Rx Medicare

As the number of deaths related to the pandemic H1N1 virus, commonly known as “swine flu,” continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.

Read More…

Related Posts

• Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu
• EVM Contributes To Council Of Europe Hearing On “The Handling Of The H1N1 Pandemic: More Transparency Needed?”
• Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• Statement By The Welsh Assembly Government On Latest Developments In Respect Of The Influenza A (H1N1) Swine Flu Pandemic
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Health Canada Approves Pandemic H1N1 Flu Vaccine For Canadians
• Practice Fusion Identifies 300,000 High-Risk Patients For H1N1 Influenza Vaccine, In-line With CDC Pandemic Guidelines
• Japan Vaccinates Medical Workers Against Pandemic H1N1 Swine Flu
• USDA Conducting Confirmatory Testing On Possible Detection Of 2009 Pandemic H1N1 Influenza In U.S. Swine
• The State University Of New York Launches H1N1 Pandemic Flu Strategy
• Baxter Receives European Commission Approval For CELVAPAN H1N1 Pandemic Influenza Vaccine
• Baxter Receives EMEA Positive Opinion For CELVAPAN H1N1 Pandemic Influenza Vaccine
• European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
• Expert Urges Responsibility, Perspective In Reaction To H1N1 Flu Pandemic

Tags: begins, efficacy, h1n1, makes, pandemic, scientist, tick, unravel

This entry was posted on Wednesday, November 18th, 2009 at 6:11 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.